vimarsana.com

Page 9 - Steve Scala Cowen News Today : Breaking News, Live Updates & Top Stories | Vimarsana

GlaxoSmithKline plc (GSK) Q1 2021 Earnings Call Transcript

GlaxoSmithKline plc (GSK) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. GlaxoSmithKline plc (NYSE: GSK) Operator Good afternoon, ladies and gentlemen. And welcome to the Analyst Call on the GSK First Quarter 2021 Results. I will now hand you over to Iain Mackay, our CFO, who will introduce today s session.SPONSORED: 10 stocks we like better than GlaxoSmithKline When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade, Motley Fool Stock Advisor, has tripled the market.  

Eli Lilly and Company (LLY) Q1 2021 Earnings Call Transcript

Eli Lilly and Company (LLY) Q1 2021 Earnings Call Transcript Motley Fool Transcribers © The Motley Fool Logo of jester cap with thought bubble. Eli Lilly and Company (NYSE: LLY) Popular Searches Operator Ladies and gentlemen, thank you for standing by and welcome to the Lilly Q1 2021 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now like to turn the conference over to our host, Mr. Kevin Hern. Please go ahead.SPONSORED: 10 stocks we like better than Eli Lilly and Company When investing geniuses David and Tom Gardner have a stock tip, it can pay to listen. After all, the newsletter they have run for over a decade,

Repros Therapeutics (RPRX) Q4 2020 Earnings Call Transcript

Repros Therapeutics (RPRX) Q4 2020 Earnings Call Transcript Motley Fool Transcribing © The Motley Fool Logo of jester cap with thought bubble. Repros Therapeutics (NASDAQ: RPRX) Ladies and gentlemen, thank you for standing by. Welcome to the Royalty Pharma fourth-quarter 2020 financial results conference call. I would now like to turn the call over to George Grofik, senior vice president, head of investor relations and communications. Please go ahead, sir. George Grofik Senior Vice President, Head of Investor Relations and Communications. Thank you, operator, and good morning and good afternoon to everyone on the call. Thank you for joining us to review Royalty Pharma s fourth-quarter results. You can find the slides of this call on the investors page of our website at royaltypharma.com. Moving to Slide 3.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.